HCMT
IHE icon

Highland Capital Management (Tennessee)’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$990K Buy
+10,000
New +$901K 0.05% 240

Other funds holding IHE

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AFG
Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Highland Capital Management (Tennessee)'s IHE Position: Q2 2026 in Review

Highland Capital Management (Tennessee) opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 10,000 shares worth $990K. The stake represents 0.05% of the portfolio and ranks #240 among its holdings.

65 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Highland Capital Management (Tennessee) held 10,000 shares of iShares US Pharmaceuticals ETF worth $990K as of Q2 2026.
  • iShares US Pharmaceuticals ETF was a new Highland Capital Management (Tennessee) position in Q2 2026.
  • iShares US Pharmaceuticals ETF made up 0.05% of Highland Capital Management (Tennessee)'s portfolio in Q2 2026, its #240 holding.
  • 65 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.